GORDON MICHAEL S 4
4 · ProMIS Neurosciences Inc. · Filed Sep 18, 2024
Insider Transaction Report
Form 4
GORDON MICHAEL S
Other
Transactions
- Purchase
Common Shares, no par value
2024-09-17$1.40/sh+16,292$22,809→ 93,223 total - Purchase
Common Shares, no par value
2024-09-16$1.22/sh+76,931$94,071→ 76,931 total
Holdings
- 2,075,629(indirect: By Title 19 Promis)
Common Shares, no par value
- 48,333(indirect: By Title 19 Acies)
Common Shares, no par value
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in forty-two separate transactions, with prices ranging from $1.1200 to $1.3700 for an average weighted purchase price of $1.2228 rounded to the nearest ten thousandth. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased in each transaction.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in four separate transactions, with prices ranging from $1.37 to $1.40 for an average weighted purchase price of $1.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased in each transaction.
- [F3]By Title 19 Promis, a series of a Delaware limited liability company, of which the Reporting Person is the sole manager.
- [F4]By Title 19 Acies, a series of a Delaware limited liability company, of which the Reporting Person is the sole manager.